Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > DOUBT THAT BOB EVEN KNOWS!!!!!
View:
Post by ISAloser247 on Mar 25, 2013 9:56pm

DOUBT THAT BOB EVEN KNOWS!!!!!

.....DE-PRIORITIZING TRANSPLANTATION------INTO A '''WORLD - LEADING """" NEPHROLOGY COMPANY , WITH BOB -THE MISLEADING SKUMMmmmbag LEADING THE WAY !!!!   YEAH  , SIGN ME UP -----I BELIEVE _____ BOB IS A PHOENIX ----- even without LRT LAURA  carrying his balls !!!!  BOB IS AN "AURINIA BUTTERFLY "  COMING Out ----OUT OF ITS    ISA    COCOON -------   I BELIEVE -------- PIGS DO FLY !!!   SWINGING FOR  THE FENCES !!!!!   YEAH !

 

...the Ides have passed ,  and still ------nothing...........................................................................................................................

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities